
Jae W. Lee
Examiner (ID: 7721, Phone: (571)272-9949 , Office: P/1656 )
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656 |
| Total Applications | 1186 |
| Issued Applications | 830 |
| Pending Applications | 111 |
| Abandoned Applications | 269 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18321247
[patent_doc_number] => 20230119375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => MATERIALS AND METHODS FOR INCREASING GENE EDITING FREQUENCY
[patent_app_type] => utility
[patent_app_number] => 17/810691
[patent_app_country] => US
[patent_app_date] => 2022-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7998
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17810691
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/810691 | Materials and methods for increasing gene editing frequency | Jul 4, 2022 | Issued |
Array
(
[id] => 17946084
[patent_doc_number] => 20220333101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => COMPOSITIONS, SYSTEMS, AND METHODS FOR GENOME EDITING
[patent_app_type] => utility
[patent_app_number] => 17/810042
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17810042
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/810042 | Compositions, systems, and methods for genome editing | Jun 29, 2022 | Issued |
Array
(
[id] => 18021025
[patent_doc_number] => 20220372524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => COMPOSITIONS, SYSTEMS, AND METHODS FOR GENOME EDITING
[patent_app_type] => utility
[patent_app_number] => 17/810023
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67174
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17810023
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/810023 | Compositions, systems, and methods for genome editing | Jun 29, 2022 | Issued |
Array
(
[id] => 17945752
[patent_doc_number] => 20220332769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => MULTIVALENT PARTICLES COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/810131
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43183
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17810131
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/810131 | MULTIVALENT PARTICLES COMPOSITIONS AND METHODS OF USE | Jun 29, 2022 | Pending |
Array
(
[id] => 18748582
[patent_doc_number] => 11807881
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-07
[patent_title] => Polypeptide, fusion polypeptide, and antibiotic against gram-negative bacteria comprising same
[patent_app_type] => utility
[patent_app_number] => 17/853027
[patent_app_country] => US
[patent_app_date] => 2022-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 14910
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17853027
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/853027 | Polypeptide, fusion polypeptide, and antibiotic against gram-negative bacteria comprising same | Jun 28, 2022 | Issued |
Array
(
[id] => 19076503
[patent_doc_number] => 11945853
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-02
[patent_title] => Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides
[patent_app_type] => utility
[patent_app_number] => 17/839815
[patent_app_country] => US
[patent_app_date] => 2022-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 33
[patent_no_of_words] => 15097
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17839815
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/839815 | Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides | Jun 13, 2022 | Issued |
Array
(
[id] => 19809723
[patent_doc_number] => 12241095
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-04
[patent_title] => Modified heat-resistant DNA polymerase
[patent_app_type] => utility
[patent_app_number] => 17/839101
[patent_app_country] => US
[patent_app_date] => 2022-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 9
[patent_no_of_words] => 8913
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17839101
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/839101 | Modified heat-resistant DNA polymerase | Jun 12, 2022 | Issued |
Array
(
[id] => 18177317
[patent_doc_number] => 20230038046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => COMPOSITIONS AND METHODS FOR STROKE PREVENTION IN PEDIATRIC SICKLE CELL ANEMIA PATIENTS
[patent_app_type] => utility
[patent_app_number] => 17/837723
[patent_app_country] => US
[patent_app_date] => 2022-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16259
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17837723
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/837723 | COMPOSITIONS AND METHODS FOR STROKE PREVENTION IN PEDIATRIC SICKLE CELL ANEMIA PATIENTS | Jun 9, 2022 | Abandoned |
Array
(
[id] => 18266158
[patent_doc_number] => 20230087400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => RECOMBINANT POLYMERASES WITH INCREASED PHOTOTOLERANCE
[patent_app_type] => utility
[patent_app_number] => 17/830199
[patent_app_country] => US
[patent_app_date] => 2022-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17830199
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/830199 | Recombinant polymerases with increased phototolerance | May 31, 2022 | Issued |
Array
(
[id] => 19316911
[patent_doc_number] => 20240238451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => SINGLE-DOMAIN ANTIGEN-DEPENDENT ANTIBODY-LIKE FUSION PROTEINS
[patent_app_type] => utility
[patent_app_number] => 18/561653
[patent_app_country] => US
[patent_app_date] => 2022-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17493
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18561653
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/561653 | SINGLE-DOMAIN ANTIGEN-DEPENDENT ANTIBODY-LIKE FUSION PROTEINS | May 25, 2022 | Pending |
Array
(
[id] => 17851889
[patent_doc_number] => 20220281931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => CHEMICALLY INDUCIBLE POLYPEPTIDE POLYMERIZATION
[patent_app_type] => utility
[patent_app_number] => 17/750061
[patent_app_country] => US
[patent_app_date] => 2022-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22318
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17750061
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/750061 | CHEMICALLY INDUCIBLE POLYPEPTIDE POLYMERIZATION | May 19, 2022 | Pending |
Array
(
[id] => 18165931
[patent_doc_number] => 20230032532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => MODIFIED IMMUNE CELLS HAVING ENHANCED FUNCTION AND METHODS FOR SCREENING FOR SAME
[patent_app_type] => utility
[patent_app_number] => 17/743183
[patent_app_country] => US
[patent_app_date] => 2022-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59128
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17743183
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/743183 | Modified immune cells having enhanced function and methods for screening for same | May 11, 2022 | Issued |
Array
(
[id] => 19923191
[patent_doc_number] => 12297462
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-13
[patent_title] => Engineered transaminase polypeptides for industrial biocatalysis
[patent_app_type] => utility
[patent_app_number] => 17/742560
[patent_app_country] => US
[patent_app_date] => 2022-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37109
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17742560
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/742560 | Engineered transaminase polypeptides for industrial biocatalysis | May 11, 2022 | Issued |
Array
(
[id] => 18020954
[patent_doc_number] => 20220372453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => NON-LTR-RETROELEMENT REVERSE TRANSCRIPTASE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/741437
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16543
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17741437
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/741437 | Non-LTR-retroelement reverse transcriptase and uses thereof | May 9, 2022 | Issued |
Array
(
[id] => 17852143
[patent_doc_number] => 20220282185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => Cleaning Compositions and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/737614
[patent_app_country] => US
[patent_app_date] => 2022-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17737614
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/737614 | Cleaning compositions and uses thereof | May 4, 2022 | Issued |
Array
(
[id] => 17990179
[patent_doc_number] => 20220356216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => LIGHT-GENERATING FUSION PROTEINS CAPABLE OF SELF-ACTIVATION
[patent_app_type] => utility
[patent_app_number] => 17/737044
[patent_app_country] => US
[patent_app_date] => 2022-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16466
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17737044
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/737044 | LIGHT-GENERATING FUSION PROTEINS CAPABLE OF SELF-ACTIVATION | May 4, 2022 | Pending |
Array
(
[id] => 19738493
[patent_doc_number] => 12215312
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-04
[patent_title] => Modified organisms for improved flavor and aroma
[patent_app_type] => utility
[patent_app_number] => 17/737035
[patent_app_country] => US
[patent_app_date] => 2022-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2201
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17737035
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/737035 | Modified organisms for improved flavor and aroma | May 4, 2022 | Issued |
Array
(
[id] => 17991274
[patent_doc_number] => 20220357311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => METHODS AND COMPOSITIONS FOR THE POSITIVE SELECTION OF PROTEIN DESTABILIZERS
[patent_app_type] => utility
[patent_app_number] => 17/725407
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -66
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17725407
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/725407 | METHODS AND COMPOSITIONS FOR THE POSITIVE SELECTION OF PROTEIN DESTABILIZERS | Apr 19, 2022 | Pending |
Array
(
[id] => 19091125
[patent_doc_number] => 11952557
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-09
[patent_title] => Alpha-amylase variants and polynucleotides encoding same
[patent_app_type] => utility
[patent_app_number] => 17/702431
[patent_app_country] => US
[patent_app_date] => 2022-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84011
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17702431
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/702431 | Alpha-amylase variants and polynucleotides encoding same | Mar 22, 2022 | Issued |
Array
(
[id] => 19300441
[patent_doc_number] => 20240229010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => TUNING CRISPR/CAS9 ACTIVITY WITH CHEMICALLY MODIFIED NUCLEOTIDE SUBSTITUTIONS
[patent_app_type] => utility
[patent_app_number] => 17/698390
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8785
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17698390
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/698390 | Tuning CRISPR/Cas9 activity with chemically modified nucleotide substitutions | Mar 17, 2022 | Issued |